The emergence of percutaneous vertebral augmentation procedures pose lucrative opportunities for key players in the VCF devices market. Percutaneous vertebral augmentation is preferred to other conventional techniques because of the associated benefits such as immediate, long-term pain relief and ideal treatment modality for osteoporotic VCF.
Global Vertebral Compression Fracture Devices Market was valued at $748 million in 2015, and is expected to reach $1,109 million by 2022, supported by a CAGR of 5.7% during the forecast period 2014 – 2022. Vertebral compression fracture (VCF) generally occurs when the block-like part of a single bone of the spine (vertebra) is compressed due to trauma. Vertebral implants are used in the treatment of compression fractures of the spine as they stabilize the fracture and ease pain
Osteoporosis is the major cause of vertebral compression fractures, accounting for ~85% of all VCF cases. These fractures can also occur due to trauma, multiple myeloma, metastasis, and malignant bone tumors that may cause spine collapse. According to the American Academy of Orthopaedic Surgeons, ~750,000 cases of osteoporosis-related VCFs occur in the U.S. alone.
Ask for Sample before buying: https://www.alliedmarketresearch.com/request-sample/669
The vertebral compression fractures devices market is driven by factors such as advent of minimally invasive spine surgery techniques and rise in incidence of osteoporosis and arthritis. In addition, rise in geriatric population, short recovery period, low risk of infection, and shorter hospital stay are anticipated to boost the demand for VCF devices, globally. However, risk of post-surgical complications and stringent regulatory approval process hamper the market growth.
Balloon kyphoplasty devices segment is projected to maintain its leading trend in the global market, owing to the benefits offered by these procedures such as reduction of back pain and restoration of vertebral body height. Furthermore, vertebroplasty segment is anticipated to grow rapidly during the forecast period.
Do Enquire about Report: https://www.alliedmarketresearch.com/purchase-enquiry/669
North America is expected to dominate the global market throughout the forecast period, owing to increased adoption of VCF devices in surgery, surge in procedure volumes caused by rapidly aging population, and rise in incidence of spinal disorders and impairments, such as spinal stenosis. However, Asia-Pacific region is projected to grow rapidly, registering a CAGR of 6.7% during the forecast period. Improving healthcare infrastructures and increase in expenditures in the emerging markets, such as India and China to cater to the unmet medical needs in these countries have bolstered the market growth.
The key companies operating in the VCF devices market are Alphatec Holdings, Inc., Benvenue Medical, Depuy Synthes (Johnson & Johnson), Globus Medical, Inc., Medtronic plc, Orthovita, Inc., Osseon LLC, Stryker Corporation, VEXIM SA, and Zimmer Biomet Holdings, Inc. The other players operating in this market include Algea Therapies, Spine Wave, Inc., Spirit Spine, Stöckli Medical AG, and VEXIM SA.